Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

NCT03283670 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03283670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2016
Completion date
February 18, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, depressive disorder, treatment-resistant